About ReadyCell

ReadyCell supports the pharmacological evaluation of drug candidates to minimize costs, facilitates the success rate of candidate drugs, and speeds up new drug development.
With over 10 years of experience and 200 customers in more than 20 countries around the world, ReadyCell is the leading provider of cell-based ready-to-use products. Leveraging our expertise in specific clearance, efflux and uptake transporters, ReadyCell generates quality products approved by FDA/EMA. From small molecules to protein therapeutics, ReadyCell is your one stop shop for all your in vitro DMPK needs.
  • We develop, implement and commercialize cell-based ready-to-use kits that provide highly reliable results while reducing time and costs for our clients, so biotech and pharmaceutical companies can optimize the development cycle for new drugs. ReadyCell supports the principles of 3R (Reduce, Replace, Refine) and 5S (Seiri, Seiton, Seisō, Seiketsu, Shitsuke)
  • Our R&D department works on the expansion of our product portfolio, with the aim of developing new tools that fulfil the needs of the pharmaceutical industry. We offer our expertise, know-how, and technical and human resources to develop ad-hoc solutions.

Recent News